Johnson & Johnson (JNJ) Stock

About Johnson & Johnson

Johnson & Johnson is led by CEO Joaquin Duato, employs 138,100 people, headquartered in New Brunswick, US, publicly traded since 1943.

Johnson & Johnson (JNJ) stock trades at $255.56 with a market capitalization of $615.87B. The stock is valued at a price-to-earnings (P/E) ratio of 31.35, price-to-book of 7.79, price-to-sales of 6.67. Over the past 52 weeks the stock has ranged between $177.32 and $281.07, and currently trades 9.1% below its 52-week high. It pays a dividend yielding 1.98%.

On profitability, Johnson & Johnson generates a return on equity (ROE) of 25.74%, above the typical market range of roughly 12-15%, return on capital employed of 17.96%, an operating margin of 26.87%, a net profit margin of 21.48%.

In its most recent fiscal year, Johnson & Johnson reported annual revenue of $94.2B, net profit of $26.8B. Over the last 5 fiscal years, revenue grew at an average annual rate of 2.7%, and net profit grew at an average annual rate of 12.7%. Over that span net profit grew faster than revenue, so net margin widened.

The balance sheet shows a debt-to-equity ratio of 0.58, a current ratio of 1.03, total assets of $199.2B, $19.7B in cash and equivalents.

JNJ has an average daily trading volume of 7,613,513 shares, a beta of 0.23 (historically less volatile than the overall market).